Coronavirus Update: Moderna Hold Up, Sanofi and Regeneron's Kevzara Fails In Phase III

IL-6 Drugs Down But Not Out

Delay to Moderna's Phase III plans adds to the biotech's rollercoaster ride, but its CEO insists it is still on track.  

Firework_Store
Seaside, Oregon: A masked vendor selling fireworks ahead of America's 4th July celebrations.

COVID-19 vaccine frontrunner Moderna Inc. has been hit by reports that the start of its Phase III trial could be set back.

The 30,000-patient trial of Moderna’s mRNA-based candidate MRNA-1273 was expected to start next week but is understood to have been...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip